Thomson Reuters Launches New Competitive Intelligence Solution for the Pharmaceutical Industry
(Thomson Reuters ONE) -
Thomson Reuters Cortellis(TM) set to transform life sciences information market
with unrivalled drug R&D content and latest information management technology
Philadelphia, PA, London, UK, October 27, 2011 - Thomson Reuters today announced
the launch of Thomson Reuters Cortellis(TM), the next generation solution for
the life sciences industry that brings together the company's best-in-class drug
research and development data and the latest information management technology,
to transform the way pharma and biotech professionals access and use data across
the entire drug research and development life cycle
The technology will enable companies to access data hosted within Cortellis and
merge it with their own data, or with public data sources. A key element of the
technology is that it will widen access to Thomson Reuters data, allowing
customers access through an API (application programming interface), and a
Software Development Toolkit, enabling customers to build tailored applications
that meet the specific needs of their end-users.
Designed to meet the competitive intelligence needs of pharma and biotech
companies of all sizes, Cortellis includes Thomson Reuters trusted competitive
intelligence content, now combined with powerful new tools to support more
detailed analysis of the drug pipeline and licensing opportunities.
The solution offers up-to-the minute information on the global drug pipeline, as
well as deal information, patent filings, plus breaking industry news and
conference coverage, integrated with TIBCO Spotfire® visualization and analysis
tools, including a pipeline competition matrix and a pipeline funnel charting
tool.
"The launch of Cortellis is a major event for both Thomson Reuters and the life
sciences industry," said Jon Brett-Harris, executive vice president at Thomson
Reuters. "The way in which the industry wants to use and interact with our
information is changing and we have responded to this demand, creating an
innovative solution to facilitate this. We are confident Cortellis will exceed
the expectations of our clients, offering them the prospect of faster, more
informed decisions than was previously possible."
Thomson Reuters Cortellis delivers impressive search speeds and more relevant
results due to an all new search engine and a highly intuitive user interface
with new indexing and ontologies. The new search engine allows for rapid free-
text searching, making it possible for users to search across the solution's
entire drug data without the need to design complex search strategies. The
Cortellis solution is also compatible with mobile devices, including smartphones
and tablet devices, providing a more interactive user experience, and the
freedom to search and stay informed while on the go.
To learn more about Thomson Reuters Cortellis, please visit:
cortellis.thomsonreuters.com
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for
businesses and professionals. We combine industry expertise with innovative
technology to deliver critical information to leading decision makers in the
financial, legal, tax and accounting, healthcare and science and media markets,
powered by the world's most trusted news organization. With headquarters in New
York and major operations in London and Eagan, Minnesota, Thomson Reuters
employs more than 55,000 people and operates in over 100 countries. For more
information, go towww.thomsonreuters.com.
CONTACT
Paul Sandell
Manager, PR & Communications
+44 (0) 207 393 7386
paul.sandell(at)thomsonreuters.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
[HUG#1558376]
Unternehmensinformation / Kurzprofil:
Datum: 27.10.2011 - 06:02 Uhr
Sprache: Deutsch
News-ID 80744
Anzahl Zeichen: 4553
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 216 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Thomson Reuters Launches New Competitive Intelligence Solution for the Pharmaceutical Industry"
steht unter der journalistisch-redaktionellen Verantwortung von
Thomson Reuters Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
